Patents by Inventor Gordon Blunn
Gordon Blunn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11678990Abstract: A device for facilitating the formation of new bone tissue includes a body that defines an upper portion and a lower portion, the lower portion having a substantially frustum-like shape, the upper portion having a substantially cylindrical shape. The lower portion is adapted to be inserted into the medullary canal of a bone.Type: GrantFiled: June 12, 2019Date of Patent: June 20, 2023Assignees: ADLER ORTHO S.P.A., I-ETHOS MEDICAL LTDInventors: Duncan Whitwell, Adrian Taylor, Ben Kendrick, Deborah Higgs, Mark Falworth, Max Gibbons, Tom Cosker, Mike Parry, Jonathan Stevenson, Andy Johnston, Scott Sommerville, Luke Johnson, Richard Boyle, Gordon Blunn, Solomon Dadia, Panos Gikas
-
Patent number: 11413374Abstract: There is described a multiphasic osteochondral scaffold for osteochondral defect repair, the scaffold comprising a bone phase and a cartilage phase, wherein the bone phase comprises a support matrix and the cartilage phase comprises a polymeric matrix, and the scaffold comprises a non-porous layer between the bone phase and the cartilage phase. Also described is a multiphasic osteochondral scaffold for osteochondral defect repair, the scaffold comprising a bone phase and a cartilage phase, wherein the bone phase comprises a support matrix and the cartilage phase comprises a polymeric matrix, and wherein the support matrix is tapered so that the dimensions of the support matrix are less at the lower end of the support matrix than at the upper end of the support matrix.Type: GrantFiled: January 9, 2017Date of Patent: August 16, 2022Assignee: UCL BUSINESS LTDInventors: Chaozong Liu, Gordon Blunn
-
Publication number: 20210228362Abstract: A device for facilitating the formation of new bone tissue includes a body that defines an upper portion and a lower portion, the lower portion having a substantially frustum-like shape, the upper portion having a substantially cylindrical shape. The lower portion is adapted to be inserted into the medullary canal of a bone.Type: ApplicationFiled: June 12, 2019Publication date: July 29, 2021Inventors: Duncan WHITWELL, Adrian TAYLOR, Ben KENDRICK, Deborah HIGGS, Mark FALWORTH, Max GIBBONS, Tom COSKER, Mike PARRY, Jonathan STEVENSON, Andy JOHNSTON, Scott SOMMERVILLE, Luke JOHNSON, Richard BOYLE, Gordon BLUNN, Solomon DADIA, Panos GIKAS
-
Patent number: 10751201Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.Type: GrantFiled: December 1, 2017Date of Patent: August 25, 2020Assignee: Stanmore Implants Worldwide LimitedInventors: Paul Unwin, Gordon Blunn
-
Publication number: 20190209327Abstract: An implant for repairing a segmental defect in a subject's bone at a segmental defect site, the implant comprising a scaffold for implantation at the segmental defect site and the implant optionally comprising: a plate for internal fixation, the plate being attachable to or integral with the scaffold, and the plate having means for securing it to bone outside of the segmental defect site; a hollow cavity within the scaffold; a plurality of longitudinal channels within the scaffold; and or a membrane received around the scaffold.Type: ApplicationFiled: August 16, 2017Publication date: July 11, 2019Applicant: FITZBIONICS LIMITEDInventors: Noel Fitzpatrick, Jayantilal Meswania, Gordon Blunn
-
Publication number: 20190009004Abstract: There is described a multiphasic osteochondral scaffold for osteochondral defect repair, the scaffold comprising a bone phase and a cartilage phase, wherein the bone phase comprises a support matrix and the cartilage phase comprises a polymeric matrix, and the scaffold comprises a non-porous layer between the bone phase and the cartilage phase. Also described is a multiphasic osteochondral scaffold for osteochondral defect repair, the scaffold comprising a bone phase and a cartilage phase, wherein the bone phase comprises a support matrix and the cartilage phase comprises a polymeric matrix, and wherein the support matrix is tapered so that the dimensions of the support matrix are less at the lower end of the support matrix than at the upper end of the support matrix.Type: ApplicationFiled: January 9, 2017Publication date: January 10, 2019Applicant: UCL BUSINESS PLCInventors: Chaozong LIU, Gordon BLUNN
-
Patent number: 10117749Abstract: A subtalar joint implant (20) is disclosed for replacing a natural subtalar joint existing between the talus (102) and calcaneum (104) bones of a patient. In an embodiment the implant comprises talar (22) and calcaneal (24) portions that are configured to slide over each other in the implanted state. The implant is shaped so that the sliding is constrained to trajectories that involve pivoting of the talar portion relative to the calcaneal portion about a pivot point (36) or a line (38) of pivot points.Type: GrantFiled: September 11, 2015Date of Patent: November 6, 2018Assignee: UCL Business, LLCInventors: Andy Goldberg, Gordon Blunn
-
Publication number: 20180085238Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.Type: ApplicationFiled: December 1, 2017Publication date: March 29, 2018Applicant: Stanmore Implants Worldwide LimitedInventors: Paul Unwin, Gordon Blunn
-
Patent number: 9855153Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.Type: GrantFiled: November 23, 2016Date of Patent: January 2, 2018Assignee: Stanmore Implants Worldwide LimitedInventors: Paul Unwin, Gordon Blunn
-
Publication number: 20170246004Abstract: A subtalar joint implant (20) is disclosed for replacing a natural subtalar joint existing between the talus (102) and calcaneum (104) bones of a patient. In an embodiment the implant comprises talar (22) and calcaneal (24) portions that are configured to slide over each other in the implanted state. The implant is shaped so that the sliding is constrained to trajectories that involve pivoting of the talar portion relative to the calcaneal portion about a pivot point (36) or a line (38) of pivot points.Type: ApplicationFiled: September 11, 2015Publication date: August 31, 2017Inventors: Andy Goldberg, Gordon Blunn
-
Publication number: 20170071763Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.Type: ApplicationFiled: November 23, 2016Publication date: March 16, 2017Applicant: Stanmore Implants Worldwide LimitedInventors: Paul Unwin, Gordon Blunn
-
Patent number: 9572674Abstract: A prosthesis for implantation in an animal or human subject, said prosthesis comprising a first component for attaching to a radius bone in use and a s second component for attaching to an ulna bone in use, the prosthesis further comprising a linkage for linking the first and second components substantially rigidly with respect to one another in use. Preferably the prosthesis is configured to allow the linkage to move relative to the first and/or second components and be retained substantially rigidly at a selected position in normal use, such that the first and second components can be retained substantially rigidly relative to one another in normal use.Type: GrantFiled: June 14, 2012Date of Patent: February 21, 2017Assignee: Fitzbionics LimitedInventors: Noel Fitzpatrick, Gordon Blunn, Jayantilal Mohanlal Meswania
-
Patent number: 9452066Abstract: A transcutaneous prosthesis which includes a first component shaped for implantation into a bone, a second component intended for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells, and a third component intended for location exterior to the skin surface having a low surface energy which deters bacterial adhesion.Type: GrantFiled: December 19, 2013Date of Patent: September 27, 2016Assignee: University College LondonInventors: Gordon Blunn, Justin Cobb, Allen Goodship, Paul Unwin
-
Publication number: 20140148912Abstract: A prosthesis for implantation in an animal or human subject, said prosthesis comprising a first component for attaching to a radius bone in use and a s second component for attaching to an ulna bone in use, the prosthesis further comprising a linage for linking the first and second components substantially rigidly with respect to one another in use. Preferably the prosthesis is configured to allow the linkage to move relative to the first and/or second components and be retained substantially rigidly at a selected position in normal use, such that the first and second components can be retained substantially rigidly relative to one another in normal use.Type: ApplicationFiled: June 14, 2012Publication date: May 29, 2014Applicant: FITZBIONICS LIMITEDInventors: Noel Fitzpatrick, Gordon Blunn, Jayantilal Mohanlal Meswania
-
Publication number: 20140107806Abstract: A transcutaneous prosthesis which includes a first component shaped for implantation into a bone, a second component intended for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells, and a third component intended for location exterior to the skin surface having a low surface energy which deters bacterial adhesion.Type: ApplicationFiled: December 19, 2013Publication date: April 17, 2014Applicant: University College LondonInventors: Gordon Blunn, Justin Cobb, Allen Goodship, Paul Unwin
-
Patent number: 8628584Abstract: A transcutaneous prosthesis includes a first component shaped for implantation into a bone, the first component including flutes or grooves on a surface thereof for deterring rotation of the prosthesis within a bone; a second component adapted for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells; and a third component adapted for location to extend from the skin surface and is adapted to extend directly from the skin surface in use, the third component having a coating of a non-stick material on an outer surface thereof, the coating having a surface energy that is lower than a surface energy of the first and second components and which is low enough to deter bacterial adhesion.Type: GrantFiled: January 3, 2006Date of Patent: January 14, 2014Assignee: University College LondonInventors: Gordon Blunn, Justin Cobb, Allen Goodship, Paul Unwin
-
Patent number: 8137409Abstract: A method of installing a transcutaneous prosthesis which includes a first component, a second component adapted for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells and a third component adapted for location to extend from the skin surface and the third component having an outer surface. The outer surface of the third component has a surface energy that is lower than a surface energy of at least the first component and which is low enough to deter bacterial adhesion. The method includes attaching the first component to a bone such that a transition from the second component to the third component is essentially at the surface of the skin and the third component extends from the skin surface when the first component is attached to a bone.Type: GrantFiled: September 13, 2010Date of Patent: March 20, 2012Assignee: University College LondonInventors: Gordon Blunn, Justin Cobb, Allen Goodship, Paul Unwin
-
Publication number: 20120035734Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.Type: ApplicationFiled: March 24, 2010Publication date: February 9, 2012Applicant: STANMORE IMPLANTS WORLDWIDE LIMITEDInventors: Paul Unwin, Gordon Blunn
-
Publication number: 20100331996Abstract: A method of installing a transcutaneous prosthesis which includes a first component, a second component adapted for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells and a third component adapted for location to extend from the skin surface and the third component having an outer surface. The outer surface of the third component has a surface energy that is lower than a surface energy of at least the first component and which is low enough to deter bacterial adhesion.Type: ApplicationFiled: September 13, 2010Publication date: December 30, 2010Applicant: University College LondonInventors: Gordon Blunn, Justin Cobb, Allen Goodship, Paul Unwin
-
Publication number: 20100249925Abstract: A method of surface treatment of at least part of a surface of an implant, said method comprising: electrochemical deposition of a layer containing calcium and phosphorus ions onto a metallic substrate; and incorporation of a therapeutic agent into said electrochemically deposited layer and an implant so treated.Type: ApplicationFiled: February 8, 2008Publication date: September 30, 2010Applicant: UCL BUSINESS PLCInventors: Gordon Blunn, Yaser Ghani, Paul Unwin